Cortene's CT38 drug trial produces "encouraging results" in chronic fatigue syndrome as it finds that lower concentrations of the drug provide better effects - thus validating their hypothesis.
In February of last year, Health Rising announced an unusual event was going to take place: a small drug company named Cortene was going to trial a new drug for chronic fatigue syndrome (ME/CFS). Cortene’s trial was unique in a number of ways. For one, it...
Since February, Health Rising has described the development of a new drug produced for chronic fatigue syndrome (ME/CFS) by a small pharmaceutical company named Cortene in three blogs: The Cortene Way: New Drug to Be Trialed in Chronic Fatigue Syndrome (ME/CFS) Soon –...
Health Rising’s Quickie Summer Donation Drive
HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT
Subscribe
Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information
Keep the information flowing! Support Health Rising during our quickie Summer Donation Drive!Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.